Each week we highlight five things affecting the life sciences industry. Here's the latest. Global health care’s push for climate resilience Following NHS England's 2020 commitment to net zero emissions by 2045, over 20 countries are adopting similar goals, aiming to create climate-resilient health ... READ MORE >
5 things to know in life sciences: Week of Feb. 5, 2024
This week we highlight the acquisition of a contract manufacturing organization to meet the high demand for GLP-1s, the funding of Australian medtech startups, and a shift in pharma from large deals to smaller acquisitions. We also examine the investment into the psychedelic medicine industry. ... READ MORE >
5 things to know in life sciences: Week of Jan. 29, 2024
This week we highlight the beginning of the first round of Inflation Reduction Act drug negotiations, the increasing popularity of co-working spaces in the biotech industry, and the mergers and acquisitions outlook in the area of central nervous system disorders. We also examine a U.S. Food and Drug ... READ MORE >
5 things to know in life sciences: Week of Jan. 22, 2024
This week we highlight the early 2024 surge in biotech initial public offerings, a potential TikTok campaign to boost vaccine uptake and proposals relating to extending the transition of European medtech regulations. We also examine the U.S. Food and Drug Administration’s warnings of potential cancer ... READ MORE >
5 things to know in life sciences: Week of Jan. 15, 2024
This week we highlight potential new medtech regulations in the UK, challenges facing CAR-T therapies and another CRISPR-based gene therapy approval. We also examine the multi-faceted approach being taken by biotech companies seeking funding or potential exits. Additionally, we look at a new device for ... READ MORE >
5 things to know in life sciences: Week of Jan. 8, 2024
This week we highlight the integration of artificial intelligence in regulatory compliance for software as a medical device (SaMD), alongside a surge in health care mergers and acquisitions totaling over $6.4 billion. We also examine the U.S. Food and Drug Administration’s approval of Florida's drug ... READ MORE >
5 things to know in life sciences: Week of Dec. 18, 2023
This week we highlight a potential U.S. Food and Drug Administration subpoena amid a probe into overseas inspections. We also look at a divestiture of an early cancer-detection company following a Federal Trade Commission challenge. Additionally, we explore the approval of the first DNA test to identify ... READ MORE >
5 things to know in life sciences: Week of Dec. 11, 2023
This week we highlight a year-end review of private biopharma financing. We also look at a plan by the federal government to potentially seize patents on certain high-cost drugs. Additionally, we explore a breakthrough in treatment of sickle cell disease, the growing impact of counterfeit drugs on the ... READ MORE >
5 things to know in life sciences: Week of Dec. 4, 2023
This week we highlight the increasing importance of environmental, social and governance (ESG) initiatives in the Asia Pacific medtech sector, as well as the potential of semaglutide, a diabetes and weight loss medication, in treating alcohol use disorder. We also look at the pharmaceutical industry's ... READ MORE >
5 things to know in life sciences: Week of Nov. 27, 2023
This week we highlight a new diagnostic device for detecting traumatic brain injury and the U.S. Food and Drug Administration’s investigation into the risk of patients developing new cancers after receiving CAR-T cell immunotherapies. We also look at a new generative artificial intelligence biotech ... READ MORE >